col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


121 Results       Page 1

 [1] 
MDPI AG: Biomolecules
  original article Date Title Authors   All Authors
1 [GO] 2023―Mar―21 Oral Immunization with Escherichia coli Nissle 1917 Expressing SARS-CoV-2 Spike Protein Induces Mucosal and Systemic Antibody Responses in Mice Giovanni Sarnelli, Alessandro Del Re, Marcella Pesce, Jie Lu, Giovanni Esposito, Walter Sanseverino, et al. (+8)
2 [GO] 2023―Mar―06 Importance of ACE2 for SARS-CoV-2 Infection of Kidney Cells Marie-Kristin Kroll, Sebastian Schloer, Peynaz Candan, Nadia Korthals, Christoph Wenzel, Hannah Ihle, et al. (+12)
3 [GO] 2023―Feb―16 Metabolic Activation of PARP as a SARS-CoV-2 Therapeutic Target-Is It a Bait for the Virus or the Best Deal We Could Ever Make with the Virus? Is AMBICA the Potential Cure? Prasanth Puthanveetil
4 [GO] 2023―Feb―14 Novel Inhibitory Role of Fenofibric Acid by Targeting Cryptic Site on the RBD of SARS-CoV-2 Jianxiang Huang, Kevin C. Chan, Ruhong Zhou
5 [GO] 2023―Jan―20 SARS-CoV-2 Induces Epithelial-Enteric Neuronal Crosstalk Stimulating VIP Release Arun Balasubramaniam, Philip R. Tedbury, Simon M. Mwangi, Yunshan Liu, Ge Li, Didier Merlin, et al. (+4)
6 [GO] 2023―Jan―13 Combining Semi-Targeted Metabolomics and Machine Learning to Identify Metabolic Alterations in the Serum and Urine of Hospitalized Patients with COVID-19 Gerard Baiges-Gaya, Simona Iftimie, Helena Castañé, Elisabet Rodríguez-Tomàs, Andrea Jiménez-Franco, Ana F. López-Azcona, et al. (+3)
7 [GO] 2023―Jan―09 Genetic Predisposition to Neurological Complications in Patients with COVID-19 Nikhil Shri Sahajpal, Alex R. Hastie, Maximilian Schieck, Ashis K. Mondal, Marc Felde, Caspar I. van der Made, et al. (+9)
8 [GO] 2023―Jan―04 Pathogenetic Mechanisms of Liver-Associated Injuries, Management, and Current Challenges in COVID-19 Patients Muhammad Naeem, Naheed Bano, Saba Manzoor, Aftab Ahmad, Nayla Munawar, Saiful Izwan Abd Razak, et al. (+3)
9 [GO] 2023―Jan―02 COVID-19 Pathology Sheds Further Light on Balance between Neutrophil Proteases and Their Inhibitors Vasuki Silva, Marko Radic
10 [GO] 2022―Dec―29 A Computer Simulation of SARS-CoV-2 Mutation Spectra for Empirical Data Characterization and Analysis Ming Xiao, Fubo Ma, Jun Yu, Jianghang Xie, Qiaozhen Zhang, Peng Liu, et al. (+3)
11 [GO] 2022―Dec―27 Heritability of Protein and Metabolite Biomarkers Associated with COVID-19 Severity: A Metabolomics and Proteomics Analysis Amelia K. Haj, Haytham Hasan, Thomas J. Raife
12 [GO] 2022―Dec―21 Metatranscriptomic Analysis Reveals Disordered Alterations in Oropharyngeal Microbiome during the Infection and Clearance Processes of SARS-CoV-2: A Warning for Secondary Infections Yongzhao Zhou, Sifen Lu, Xiaozhen Wei, Ya Hu, Honghao Li, Jing Wang, et al. (+10)
13 [GO] 2022―Dec―12 Molecular Pathogenesis of Fibrosis, Thrombosis and Surfactant Dysfunction in the Lungs of Severe COVID-19 Patients Adrian Krygier, Dagmara Szmajda-Krygier, Rafał Świechowski, Jacek Pietrzak, Agnieszka Wosiak, Damian Wodziński, Ewa Balcerczak
14 [GO] 2022―Nov―28 Structure-Based Virtual Screening and Functional Validation of Potential Hit Molecules Targeting the SARS-CoV-2 Main Protease Balasubramanian Moovarkumudalvan, Anupriya Madhukumar Geethakumari, Ramya Ramadoss, Kabir H. Biswas, Borbala Mifsud
15 [GO] 2022―Nov―24 SARS-CoV-2 Delta Variant: Interplay between Individual Mutations and Their Allosteric Synergy Kevin C. Chan, Yi Song, Zheng Xu, Chun Shang, Ruhong Zhou
16 [GO] 2022―Nov―23 Identification of Transcriptome Biomarkers for Severe COVID-19 with Machine Learning Methods Xiaohong Li, Xianchao Zhou, Shijian Ding, Lei Chen, Kaiyan Feng, Hao Li, et al. (+2)
17 [GO] 2022―Nov―23 Analysis and Identification of Bioactive Compounds of Cannabinoids in Silico for Inhibition of SARS-CoV-2 and SARS-CoV Chenxiao Chen, Hao Liang, Yanchun Deng, Xiushi Yang, Xiaoming Li, Chunsheng Hou
18 [GO] 2022―Nov―14 Subgenomic RNAs and Their Encoded Proteins Contribute to the Rapid Duplication of SARS-CoV-2 and COVID-19 Progression Yifan Zhang, Xinglong Zhang, Huiwen Zheng, Longding Liu
19 [GO] 2022―Nov―14 Gold-Based Metal Drugs as Inhibitors of Coronavirus Proteins: The Inhibition of SARS-CoV-2 Main Protease by Auranofin and Its Analogs Lara Massai, Deborah Grifagni, Alessia De De Santis, Andrea Geri, Francesca Cantini, Vito Calderone, et al. (+2)
20 [GO] 2022―Nov―14 Inhibition of SARS-CoV-2 Viral Channel Activity Using FDA-Approved Channel Modulators Independent of Variants Han-Gang Yu, Gina Sizemore, Ivan Martinez, Peter Perrotta
21 [GO] 2022―Nov―11 In Silico Protein Folding Prediction of COVID-19 Mutations and Variants Sumana Bhowmick, Tim Jing, Wei Wang, Elena Y. Zhang, Frank Zhang, Yanmin Yang
22 [GO] 2022―Nov―01 A Pathway Model to Understand the Evolution of Spike Protein Binding to ACE2 in SARS-CoV-2 Variants Ludovico Pipitò, Christopher A. Reynolds, Juan Carlos Mobarec, Owen Vickery, Giuseppe Deganutti
23 [GO] 2022―Oct―24 Renoprotective Effects of Luteolin: Therapeutic Potential for COVID-19-Associated Acute Kidney Injuries Lúcio Ricardo Leite Diniz, Hatem A. Elshabrawy, Marilia Trindade S. Souza, Allana Brunna Sucupira Duarte, Nikhil Madhav, Damião Pergentino de Sousa
24 [GO] 2022―Oct―17 Lipidomics Revealed Plasma Phospholipid Profile Differences between Deceased and Recovered COVID-19 Patients Neven Žarković, Biserka Orehovec, Bruno Baršić, Marko Tarle, Marta Kmet, Ivica Lukšić, et al. (+4)
25 [GO] 2022―Oct―10 COVID-GWAB: A Web-Based Prediction of COVID-19 Host Genes via Network Boosting of Genome-Wide Association Data Seungbyn Baek, Sunmo Yang, Insuk Lee
26 [GO] 2022―Sep―26 A Study on the Nature of SARS-CoV-2 Using the Shell Disorder Models: Reproducibility, Evolution, Spread, and Attenuation Gerard Kian-Meng Goh, A. Keith Dunker, James A. Foster, Vladimir N. Uversky
27 [GO] 2022―Sep―26 Elevated Extracellular HSP72 and Blunted Heat Shock Response in Severe COVID-19 Patients Mariana Kras Borges Russo, Lucas Stahlhöfer Kowalewski, Gabriella Richter da Natividade, Carlos Henrique de Lemos Muller, Helena Trevisan Schroeder, Patrícia Martins Bock, et al. (+11)
28 [GO] 2022―Sep―16 The Role of Disordered Regions in Orchestrating the Properties of Multidomain Proteins: The SARS-CoV-2 Nucleocapsid Protein and Its Interaction with Enoxaparin Marco Schiavina, Letizia Pontoriero, Giuseppe Tagliaferro, Roberta Pierattelli, Isabella C. Felli
29 [GO] 2022―Sep―08 SARS-CoV-2 Invasion and Pathological Links to Prion Disease Walter J. Lukiw, Vivian R. Jaber, Aileen I. Pogue, Yuhai Zhao
30 [GO] 2022―Sep―06 t6A and ms2t6A Modified Nucleosides in Serum and Urine as Strong Candidate Biomarkers of COVID-19 Infection and Severity Yu Nagayoshi, Kayo Nishiguchi, Ryosuke Yamamura, Takeshi Chujo, Hiroyuki Oshiumi, Hiroko Nagata, et al. (+15)
31 [GO] 2022―Sep―01 SARS-CoV-2 and Skin: New Insights and Perspectives Gerardo Cazzato, Eliano Cascardi, Anna Colagrande, Caterina Foti, Alessandra Stellacci, Maricla Marrone, et al. (+9)
32 [GO] 2022―Aug―25 Impact of SARS-CoV-2 RBD Mutations on the Production of a Recombinant RBD Fusion Protein in Mammalian Cells Guillaume Gerez, Jerome Martinez, Christophe Steinbrugger, Sandra Bouanich, Johanna Dimino, Corine Piegay, et al. (+3)
33 [GO] 2022―Aug―22 Prediction of Potential Commercially Available Inhibitors against SARS-CoV-2 by Multi-Task Deep Learning Model Fan Hu, Jiaxin Jiang, Peng Yin
34 [GO] 2022―Aug―03 CoVM2: Molecular Biological Data Integration of SARS-CoV-2 Proteins in a Macro-to-Micro Method Hongjun Chen, Xiaotian Hu, Yanshi Hu, Jiawen Zhou, Ming Chen
35 [GO] 2022―Aug―01 Nanoscale Technologies in the Fight against COVID-19: From Innovative Nanomaterials to Computer-Aided Discovery of Potential Antiviral Plant-Derived Drugs Nunzio Iraci, Carmelo Corsaro, Salvatore V. Giofrè, Giulia Neri, Angela Maria Mezzasalma, Martina Vacalebre, et al. (+4)
36 [GO] 2022―Aug―01 Targeting the YXXΦ Motifs of the SARS Coronaviruses 1 and 2 ORF3a Peptides by In Silico Analysis to Predict Novel Virus-Host Interactions Athanassios Kakkanas, Eirini Karamichali, Efthymia Ioanna Koufogeorgou, Stathis D. Kotsakis, Urania Georgopoulou, Pelagia Foka
37 [GO] 2022―Jul―28 NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study Laure Morimont, Mélanie Dechamps, Clara David, Céline Bouvy, Constant Gillot, Hélène Haguet, et al. (+9)
38 [GO] 2022―Jul―18 Infection Rate of Respiratory Viruses in the Pandemic SARS-CoV-2 Period Considering Symptomatic Patients: Two Years of Ongoing Observations Gaetana Costanza, Pierpaolo Paba, Marco Ciotti, Domenico Ombres, Stefano Di Carlo, Fabbio Marcuccilli, et al. (+14)
39 [GO] 2022―Jul―12 COVID-19 and Parkinsonism: A Critical Appraisal Francesco Cavallieri, Valentina Fioravanti, Francesco Bove, Eleonora Del Prete, Sara Meoni, Sara Grisanti, et al. (+4)
40 [GO] 2022―Jul―12 Pathological Features and Neuroinflammatory Mechanisms of SARS-CoV-2 in the Brain and Potential Therapeutic Approaches Aisha Sodagar, Rasab Javed, Hira Tahir, Saiful Izwan Abd Razak, Muhammad Shakir, Muhammad Naeem, et al. (+6)
41 [GO] 2022―Jul―12 Host-Genome Similarity Characterizes the Adaption of SARS-CoV-2 to Humans Weitao Sun
42 [GO] 2022―Jul―11 Integrating Conformational Dynamics and Perturbation-Based Network Modeling for Mutational Profiling of Binding and Allostery in the SARS-CoV-2 Spike Variant Complexes with Antibodies: Balancing Local and Global Determinants of Mutational Escape Mechanisms Gennady Verkhivker, Steve Agajanian, Ryan Kassab, Keerthi Krishnan
43 [GO] 2022―Jul―05 Saquinavir: From HIV to COVID-19 and Cancer Treatment Mariana Pereira, Nuno Vale
44 [GO] 2022―Jul―02 NMR Reveals Specific Tracts within the Intrinsically Disordered Regions of the SARS-CoV-2 Nucleocapsid Protein Involved in RNA Encountering Letizia Pontoriero, Marco Schiavina, Sophie M. Korn, Andreas Schlundt, Roberta Pierattelli, Isabella C. Felli
45 [GO] 2022―Jun―24 Usefulness of the Measurement of Serum Paraoxonase-1 Arylesterase Activity in the Diagnoses of COVID-19 Xavier Gabaldó, Màrius Juanpere, Helena Castañé, Elisabet Rodríguez-Tomàs, Ana Felisa López-Azcona, Gerard Baiges-Gaya, et al. (+12)
46 [GO] 2022―Jun―14 SCD14-ST and New Generation Inflammatory Biomarkers in the Prediction of COVID-19 Outcome Emanuela Galliera, Luca Massaccesi, Lina Yu, Jianwen He, Marco Ranucci, Massimiliano M. Corsi Romanelli
47 [GO] 2022―Jun―04 Filterability of Erythrocytes in Patients with COVID-19 Dmitry S. Prudinnik, Elena I. Sinauridze, Soslan S. Shakhidzhanov, Elizaveta A. Bovt, Denis N. Protsenko, Alexander G. Rumyantsev, Fazoil I. Ataullakhanov
48 [GO] 2022―May―26 AI-Aided Design of Novel Targeted Covalent Inhibitors against SARS-CoV-2 Bowen Tang, Fengming He, Dongpeng Liu, Fei He, Tong Wu, Meijuan Fang, et al. (+3)
49 [GO] 2022―May―11 Matrix Metalloproteinases in Health and Disease in the Times of COVID-19 Carlos Fernandez-Patron, Eugenio Hardy
50 [GO] 2022―May―11 Immune-Related Protein Interaction Network in Severe COVID-19 Patients toward the Identification of Key Proteins and Drug Repurposing Pakorn Sagulkoo, Apichat Suratanee, Kitiporn Plaimas
51 [GO] 2022―Apr―26 Shell Disorder Models Detect That Omicron Has Harder Shells with Attenuation but Is Not a Descendant of the Wuhan-Hu-1 SARS-CoV-2 Gerard Kian-Meng Goh, A. Keith Dunker, James A. Foster, Vladimir N. Uversky
52 [GO] 2022―Apr―26 COVID-19 and the Brain: The Neuropathological Italian Experience on 33 Adult Autopsies Viscardo P. Fabbri, Mattia Riefolo, Tiziana Lazzarotto, Liliana Gabrielli, Giovanna Cenacchi, Carmine Gallo, et al. (+7)
53 [GO] 2022―Apr―20 Matrix Metalloproteinases on Severe COVID-19 Lung Disease Pathogenesis: Cooperative Actions of MMP-8/MMP-2 Axis on Immune Response through HLA-G Shedding and Oxidative Stress Pedro V. da Silva-Neto, Valéria B. do Valle, Carlos A. Fuzo, Talita M. Fernandes, Diana M. Toro, Thais F. C. Fraga-Silva, et al. (+31)
54 [GO] 2022―Apr―14 Mutational Effect of Some Major COVID-19 Variants on Binding of the S Protein to ACE2 Zhendong Li, John Z. H. Zhang
55 [GO] 2022―Apr―08 Long COVID-19 in Children: From the Pathogenesis to the Biologically Plausible Roots of the Syndrome Michele Piazza, Maria Di Cicco, Luca Pecoraro, Michele Ghezzi, Diego Peroni, Pasquale Comberiati
56 [GO] 2022―Apr―05 Progress in Assays of HMGB1 Levels in Human Plasma-The Potential Prognostic Value in COVID-19 Michal Štros, Eva Volfová Polanská, Tereza Hlaváčová, Petr Skládal
57 [GO] 2022―Mar―23 The rs8176740 T/A and rs512770 T/C Genetic Variants of the ABO Gene Increased the Risk of COVID-19, as well as the Plasma Concentration Platelets Gilberto Vargas-Alarcón, Julian Ramírez-Bello, Rosalinda Posadas-Sánchez, Gustavo Rojas-Velasco, Alberto López-Reyes, Laura Martínez-Gómez, et al. (+5)
58 [GO] 2022―Mar―22 In Silico Insights towards the Identification of SARS-CoV-2 NSP13 Helicase Druggable Pockets Federico Ricci, Rosaria Gitto, Giovanna Pitasi, Laura De Luca
59 [GO] 2022―Mar―15 Circulating Levels of PD-L1, TIM-3 and MMP-7 Are Promising Biomarkers to Differentiate COVID-19 Patients That Require Invasive Mechanical Ventilation Leslie Chavez-Galan, Andy Ruiz, Karen Martinez-Espinosa, Hiram Aguilar-Duran, Martha Torres, Ramces Falfan-Valencia, et al. (+3)
60 [GO] 2022―Mar―14 Upregulated Proteasome Subunits in COVID-19 Patients: A Link with Hypoxemia, Lymphopenia and Inflammation Enrique Alfaro, Elena Díaz-García, Sara García-Tovar, Ester Zamarrón, Alberto Mangas, Raúl Galera, et al. (+3)
61 [GO] 2022―Feb―14 Targeting the Ubiquitylation and ISGylation Machinery for the Treatment of COVID-19 George Vere, Md Rashadul Alam, Sam Farrar, Rachel Kealy, Benedikt M. Kessler, Darragh P. O’Brien, Adán Pinto-Fernández
62 [GO] 2022―Feb―14 Spectrum of Kidney Injury Following COVID-19 Disease: Renal Biopsy Findings in a Single Italian Pathology Service Alessandro Gambella, Antonella Barreca, Luigi Biancone, Dario Roccatello, Licia Peruzzi, Luca Besso, et al. (+4)
63 [GO] 2022―Feb―09 Role of Urinary Kidney Stress Biomarkers for Early Recognition of Subclinical Acute Kidney Injury in Critically Ill COVID-19 Patients Gustavo Casas-Aparicio, Claudia Alvarado-de la Barrera, David Escamilla-Illescas, Isabel León-Rodríguez, Perla Mariana Del Río-Estrada, Natalia Calderón-Dávila, et al. (+9)
64 [GO] 2022―Feb―07 Immunomodulatory Potential of Non-Classical HLA-G in Infections including COVID-19 and Parasitic Diseases Sajad Rashidi, Carmen Vieira, Renu Tuteja, Reza Mansouri, Mohammad Ali-Hassanzadeh, Antonio Muro, et al. (+2)
65 [GO] 2022―Jan―24 Looking at COVID-19 from a Systems Biology Perspective Emily Samuela Turilli, Marta Lualdi, Mauro Fasano
66 [GO] 2022―Jan―06 Calcium Signaling Pathway Is Involved in the Shedding of ACE2 Catalytic Ectodomain: New Insights for Clinical and Therapeutic Applications of ACE2 for COVID-19 Artemio García-Escobar, Silvio Vera-Vera, Alfonso Jurado-Román, Santiago Jiménez-Valero, Guillermo Galeote, Raúl Moreno
67 [GO] 2021―Dec―24 Sex-Related Factors in Cardiovascular Complications Associated to COVID-19 Francesca Megiorni, Paola Pontecorvi, Giulia Gerini, Eleni Anastasiadou, Cinzia Marchese, Simona Ceccarelli
68 [GO] 2021―Dec―03 The Nuts and Bolts of SARS-CoV-2 Spike Receptor-Binding Domain Heterologous Expression Mariano Maffei, Linda Celeste Montemiglio, Grazia Vitagliano, Luigi Fedele, Shaila Sellathurai, Federica Bucci, et al. (+7)
69 [GO] 2021―Oct―28 Glycan Epitopes and Potential Glycoside Antagonists of DC-SIGN Involved in COVID-19: In Silico Study Meina Gao, Hui Li, Chenghao Ye, Kaixian Chen, Hualiang Jiang, Kunqian Yu
70 [GO] 2021―Oct―20 Mechanisms of Immunothrombosis by SARS-CoV-2 María Teresa Hernández-Huerta, Alma Dolores Pérez-Santiago, Laura Pérez-Campos Mayoral, Luis Manuel Sánchez Navarro, Francisco Javier Rodal Canales, Abraham Majluf-Cruz, et al. (+7)
71 [GO] 2021―Oct―11 Shortening Epitopes to Survive: The Case of SARS-CoV-2 Lambda Variant Stefano Pascarella, Massimo Ciccozzi, Martina Bianchi, Domenico Benvenuto, Marta Giovanetti, Roberto Cauda, Antonio Cassone
72 [GO] 2021―Sep―28 Fetuin-A Deficiency but Not Pentraxin 3, FGF-21, or Irisin, Predisposes to More Serious COVID-19 Course Michał Kukla, Tomasz Menżyk, Marcin Dembiński, Marek Winiarski, Aleksander Garlicki, Monika Bociąga-Jasik, et al. (+13)
73 [GO] 2021―Sep―18 The Immunological Therapeutic Strategies for Controlling Multiple Sclerosis: Considerations during the COVID-19 Pandemic Maryam Azimzadeh, Nora Möhn, Sajjad Ghane Ezabadi, Zahra Moghimi Esfandabadi, Alireza Soleimani, Elaheh Ranjbar, et al. (+4)
74 [GO] 2021―Sep―17 Further Findings Concerning Endothelial Damage in COVID-19 Patients Monica Gelzo, Sara Cacciapuoti, Biagio Pinchera, Annunziata De Rosa, Gustavo Cernera, Filippo Scialò, et al. (+7)
75 [GO] 2021―Sep―15 Bioguided Isolation of Cyclopenin Analogues as Potential SARS-CoV-2 Mpro Inhibitors from Penicillium citrinum TDPEF34 Bathini Thissera, Ahmed M. Sayed, Marwa H. A. Hassan, Sayed F. Abdelwahab, Ngozi Amaeze, Valeria T. Semler, et al. (+5)
76 [GO] 2021―Aug―26 Mutations of SARS-CoV-2 RBD May Alter Its Molecular Structure to Improve Its Infection Efficiency Ahmed L. Alaofi, Mudassar Shahid
77 [GO] 2021―Aug―20 Molecular Dynamics Simulation Study of the Interaction between Human Angiotensin Converting Enzyme 2 and Spike Protein Receptor Binding Domain of the SARS-CoV-2 B.1.617 Variant Priya Antony, Ranjit Vijayan
78 [GO] 2021―Aug―17 HMGB1-TIM3-HO1: A New Pathway of Inflammation in Skin of SARS-CoV-2 Patients? A Retrospective Pilot Study Gerardo Cazzato, Anna Colagrande, Antonietta Cimmino, Gerolamo Cicco, Vincenza Sara Scarcella, Paola Tarantino, et al. (+10)
79 [GO] 2021―Aug―13 Cytokine Storms in the Course of COVID-19 and Haemophagocytic Lymphohistiocytosis in Pregnant and Postpartum Women Aleksandra Obuchowska, Arkadiusz Standyło, Karolina Obuchowska, Żaneta Kimber-Trojnar, Bożena Leszczyńska-Gorzelak
80 [GO] 2021―Aug―02 Diagnostic Significance of Serum Galectin-3 in Hospitalized Patients with COVID-19-A Preliminary Study Beata Kuśnierz-Cabala, Barbara Maziarz, Paulina Dumnicka, Marcin Dembiński, Maria Kapusta, Monika Bociąga-Jasik, et al. (+4)
81 [GO] 2021―Jul―30 Relevance of BET Family Proteins in SARS-CoV-2 Infection Nieves Lara-Ureña, Mario García-Domínguez
82 [GO] 2021―Jul―28 Full-Length Recombinant hSP-D Binds and Inhibits SARS-CoV-2 Raquel Arroyo, Shawn N. Grant, Miriam Colombo, Lucia Salvioni, Fabio Corsi, Marta Truffi, et al. (+5)
83 [GO] 2021―Jul―20 Adventitial Microcirculation Is a Major Target of SARS-CoV-2-Mediated Vascular Inflammation Francesco Vasuri, Carmen Ciavarella, Salvatore Collura, Chiara Mascoli, Sabrina Valente, Alessio Degiovanni, et al. (+3)
84 [GO] 2021―Jul―19 Interference of Polydatin/Resveratrol in the ACE2:Spike Recognition during COVID-19 Infection. A Focus on Their Potential Mechanism of Action through Computational and Biochemical Assays Fulvio Perrella, Federico Coppola, Alessio Petrone, Chiara Platella, Daniela Montesarchio, Annarita Stringaro, et al. (+4)
85 [GO] 2021―Jul―13 COVID-19 Vaccines and Thrombosis-Roadblock or Dead-End Street? Kenneth Lundstrom, Debmalya Barh, Bruce D. Uhal, Kazuo Takayama, Alaa A. A. Aljabali, Tarek Mohamed Abd El-Aziz, et al. (+20)
86 [GO] 2021―Jul―06 COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies Renuka Raman, Krishna J. Patel, Kishu Ranjan
87 [GO] 2021―Jul―05 Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers-Relevance to COVID-19 Graham J. Moore, Jose M. Pires, Konstantinos Kelaidonis, Laura Kate Gadanec, Anthony Zulli, Vasso Apostolopoulos, John M. Matsoukas
88 [GO] 2021―Jun―22 Remdesivir MD Simulations Suggest a More Favourable Binding to SARS-CoV-2 RNA Dependent RNA Polymerase Mutant P323L Than Wild-Type Anwar Mohammad, Fahd Al-Mulla, Dong-Qing Wei, Jehad Abubaker
89 [GO] 2021―Jun―18 Genome-Wide Analysis of Codon Usage Patterns of SARS-CoV-2 Virus Reveals Global Heterogeneity of COVID-19 Saadullah Khattak, Mohd Ahmar Rauf, Qamar Zaman, Yasir Ali, Shabeen Fatima, Pir Muhammad, et al. (+6)
90 [GO] 2021―Jun―14 Hyperactivated RAGE in Comorbidities as a Risk Factor for Severe COVID-19-The Role of RAGE-RAS Crosstalk Sara Chiappalupi, Laura Salvadori, Rosario Donato, Francesca Riuzzi, Guglielmo Sorci
91 [GO] 2021―Jun―08 Can Antiviral Activity of Licorice Help Fight COVID-19 Infection? Luisa Diomede, Marten Beeg, Alessio Gamba, Oscar Fumagalli, Marco Gobbi, Mario Salmona
92 [GO] 2021―Jun―07 SARS-CoV-2 and Skin: The Pathologist’s Point of View Gerardo Cazzato, Giulia Mazzia, Antonietta Cimmino, Anna Colagrande, Sara Sablone, Teresa Lettini, et al. (+10)
93 [GO] 2021―May―28 Binding of SARS-CoV Covalent Non-Covalent Inhibitors to the SARS-CoV-2 Papain-Like Protease and Ovarian Tumor Domain Deubiquitinases Dakshinamurthy Sivakumar, Matthias Stein
94 [GO] 2021―May―26 Lower Gene Expression of Angiotensin Converting Enzyme 2 Receptor in Lung Tissues of Smokers with COVID-19 Pneumonia Francesca Lunardi, Francesco Fortarezza, Luca Vedovelli, Federica Pezzuto, Annalisa Boscolo, Marco Rossato, et al. (+7)
95 [GO] 2021―May―24 Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement Mathew A. Coban, Juliet Morrison, Sushila Maharjan, David Hyram Hernandez Medina, Wanlu Li, Yu Shrike Zhang, et al. (+6)
96 [GO] 2021―May―06 Immunothrombosis in COVID-19: Implications of Neutrophil Extracellular Traps Brandon Bautista-Becerril, Rebeca Campi-Caballero, Samuel Sevilla-Fuentes, Laura M. Hernández-Regino, Alejandro Hanono, Al Flores-Bustamante, et al. (+6)
97 [GO] 2021―Apr―29 Computational Identification of Potential Anti-Inflammatory Natural Compounds Targeting the p38 Mitogen-Activated Protein Kinase (MAPK): Implications for COVID-19-Induced Cytokine Storm Seth O. Asiedu, Samuel K. Kwofie, Emmanuel Broni, Michael D. Wilson
98 [GO] 2021―Apr―27 Linking COVID-19 and Heme-Driven Pathophysiologies: A Combined Computational-Experimental Approach Marie-Thérèse Hopp, Daniel Domingo-Fernández, Yojana Gadiya, Milena S. Detzel, Regina Graf, Benjamin F. Schmalohr, et al. (+3)
99 [GO] 2021―Apr―20 SARS-CoV-2 Mpro: A Potential Target for Peptidomimetics and Small-Molecule Inhibitors Andrea Citarella, Angela Scala, Anna Piperno, Nicola Micale
100 [GO] 2021―Apr―20 Protein Intrinsic Disorder and Evolvability of MERS-CoV Vladimir N. Uversky, Elrashdy M. Redwan, Abdullah A. Aljadawi
101 [GO] 2021―Apr―14 Molecular Simulation-Based Investigation of Highly Potent Natural Products to Abrogate Formation of the nsp10-nsp16 Complex of SARS-CoV-2 Anwar Mohammad, Eman Alshawaf, Sulaiman K. Marafie, Mohamed Abu-Farha, Fahd Al-Mulla, Jehad Abubaker
102 [GO] 2021―Mar―19 Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19) Amr El-Demerdash, Ahmed M. Metwaly, Afnan Hassan, Tarek Mohamed Abd El-Aziz, Eslam B. Elkaeed, Ibrahim H. Eissa, et al. (+2)
103 [GO] 2021―Mar―15 COVID-19 Rapid Antigen Test as Screening Strategy at Points of Entry: Experience in Lazio Region, Central Italy, August-October 2020 Francesca Colavita, Francesco Vairo, Silvia Meschi, Maria Beatrice Valli, Eleonora Lalle, Concetta Castilletti, et al. (+9)
104 [GO] 2021―Mar―09 Urgent Need for Field Surveys of Coronaviruses in Southeast Asia to Understand the SARS-CoV-2 Phylogeny and Risk Assessment for Future Outbreaks Murat Seyran, Sk. Sarif Hassan, Vladimir N. Uversky, Pabitra Pal Choudhury, Bruce D. Uhal, Kenneth Lundstrom, et al. (+15)
105 [GO] 2021―Mar―08 Targeting MMP-Regulation of Inflammation to Increase Metabolic Tolerance to COVID-19 Pathologies: A Hypothesis Eugenio Hardy, Carlos Fernandez-Patron
106 [GO] 2021―Feb―22 Screening and Molecular Modeling Evaluation of Food Peptides to Inhibit Key Targets of COVID-19 Virus Ai-Min Shi, Rui Guo, Qiang Wang, Jin-Rong Zhou
107 [GO] 2021―Feb―18 Multivalent Display of SARS-CoV-2 Spike (RBD Domain) of COVID-19 to Nanomaterial, Protein Ferritin Nanocages Umesh Kalathiya, Monikaben Padariya, Robin Fahraeus, Soumyananda Chakraborti, Ted R. Hupp
108 [GO] 2021―Feb―04 In Silico Screening of Natural Products Isolated from Mexican Herbal Medicines against COVID-19 Nadia A. Rivero-Segura, Juan C. Gomez-Verjan
109 [GO] 2021―Jan―31 Research Progress on the Cardiac Injury from ACE2 Targeting in SARS-CoV-2 Infection Hao Sun, Xiaojuan Su, Lingyi Huang, Dezhi Mu, Yi Qu
110 [GO] 2021―Jan―13 Cytokines and Chemokines in SARS-CoV-2 Infections-Therapeutic Strategies Targeting Cytokine Storm Alexandra Pum, Maria Ennemoser, Tiziana Adage, Andreas J. Kungl
111 [GO] 2021―Jan―08 Bioactive Terpenes and Their Derivatives as Potential SARS-CoV-2 Proteases Inhibitors from Molecular Modeling Studies Lúcio Ricardo Leite Diniz, Yunierkis Perez-Castillo, Hatem A. Elshabrawy, Carlos da Silva Maia Bezerra Filho, Damião Pergentino de Sousa
112 [GO] 2020―Dec―31 Potential Medicinal Plants for the Treatment of Dengue Fever and Severe Acute Respiratory Syndrome-Coronavirus Mohammed S. M. Saleh, Yusof Kamisah
113 [GO] 2020―Dec―28 A Computational Approach to Explore the Interaction of Semisynthetic Nitrogenous Heterocyclic Compounds with the SARS-CoV-2 Main Protease Alejandro Llanes, Héctor Cruz, Viet D. Nguyen, Oleg V. Larionov, Patricia L. Fernández
114 [GO] 2020―Dec―14 Picomolar SARS-CoV-2 Neutralization Using Multi-Arm PEG Nanobody Constructs Ainhoa Moliner-Morro, Daniel J. Sheward, Vivien Karl, Laura Perez Vidakovics, Ben Murrell, Gerald M. McInerney, Leo Hanke
115 [GO] 2020―Oct―16 A Possible Path towards Rapid Development of Live-Attenuated SARS-CoV-2 Vaccines: Plunging into the Natural Pool German Todorov, Vladimir N. Uversky
116 [GO] 2020―Sep―21 Recognition of Potential COVID-19 Drug Treatments through the Study of Existing Protein-Drug and Protein-Protein Structures: An Analysis of Kinetically Active Residues Ognjen Perišić
117 [GO] 2020―Sep―14 Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics? Fatma Elrashdy, Elrashdy M. Redwan, Vladimir N. Uversky
118 [GO] 2020―Aug―12 Targeting Endothelial Dysfunction in Eight Extreme-Critically Ill Patients with COVID-19 Using the Anti-Adrenomedullin Antibody Adrecizumab (HAM8101) Mahir Karakas, Dominik Jarczak, Martin Becker, Kevin Roedl, Marylyn M. Addo, Frauke Hein, et al. (+7)
119 [GO] 2020―Jun―24 Class A G Protein-Coupled Receptor Antagonist Famotidine as a Therapeutic Alternative Against SARS-CoV2: An In Silico Analysis Joseph T. Ortega, Maria Luisa Serrano, Beata Jastrzebska
120 [GO] 2020―Mar―02 Antiviral Action of Tryptanthrin Isolated from Strobilanthes cusia Leaf against Human Coronavirus NL63 Yu-Chi Tsai, Chia-Lin Lee, Hung-Rong Yen, Young-Sheng Chang, Yu-Ping Lin, Su-Hua Huang, Cheng-Wen Lin
121 [GO] 2020―Feb―21 Rigidity of the Outer Shell Predicted by a Protein Intrinsic Disorder Model Sheds Light on the COVID-19 (Wuhan-2019-nCoV) Infectivity Gerard Kian-Meng Goh, A. Keith Dunker, James A. Foster, Vladimir N. Uversky
 [1] 

121 Results       Page 1


[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.007 sec